Dasotraline Completed Phase 3 Trials for Binge Eating Disorder (BED) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03107026 | A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder | |
| NCT02684279 | Dasotraline Binge Eating Disorder Extension Study |